We appreciate the comments from Roatta and Farina concerning our paper (Andersson et al. 2012) on the molecular mechanism of adrenergic-induced force potentiation in fast twitch skeletal muscle. Our study explores how modulation of the ryanodine receptor (RyR1), which regulates sarcoplasmic reticulum (SR) Ca2+ release, can affect skeletal muscle force production. The hypothesis we tested was that protein kinase A (PKA)-mediated phosphorylation of the RyR1 enhances twitch force in the fast twitch skeletal muscle in mice. Inotropic effects in skeletal muscle following adrenergic receptor stimulation have been reported in many studies (Cairns & Dulhunty, 1993a; Cairns et al. 1993; Liu et al. 1997). The potentiating effect on isometric twitch force is evident in many different animal species (Bowman, 1980). We and others observe a small, but robust, increase in twitch force (∼10–20%) after adrenergic stimulation (Tashiro, 1973; Cairns & Dulhunty, 1993a; Cairns et al. 1993; Liu et al. 1997; Andersson et al. 2012). More recently, changes in Ca2+ handling have been linked to force potentiation (Cairns & Dulhunty, 1993a,b; Cairns et al. 1993; Liu et al. 1997). Cairns et al. (Cairns & Dulhunty, 1993a,b; Cairns et al. 1993) demonstrated enhanced SR Ca2+ release as the underlying mechanism for increased inotropy. In our paper we show that RyR1 PKA phosphorylation results in increased SR Ca2+ release and is a molecular mechanism underlying fast twitch skeletal muscle inotropy in mice. Indeed, mice harbouring RyR1 that cannot be PKA phosphorylated due to a substitution of an alanine for the serine phosphorylated by PKA in RyR1 fail to respond to catecholamines in terms of increasing the calcium transient or muscle force production (Andersson et al. 2012). Roatta and Farina challenge the view that adrenergic activation increases muscle force development in humans (Roatta & Farina, 2011). They correctly point out that the effect of adrenergic potentiation of skeletal muscle force has been difficult to detect in humans. Moreover, Roatta and Farina note that adrenergic stimulation of slow twitch (type 1) muscle can reduce twitch tension (Tashiro, 1973; Bowman, 1980). With the exception of some postural muscles (e.g. soleus), the mice have predominantly fast twitch fibres (Mathewson et al. 2012). In contrast, human muscles exhibit a substantial mix in fibre type and have considerably more slow twitch fibres, ∼40–70% are type 1 fibres in most human muscles (Johnson et al. 1973). Interestingly, the ability to maintain isometric force production in humans correlates with blood catecholamine levels (French et al. 2007). Therefore, the effect of adrenergic stimulation in human in vivo muscle experiments probably reflects the balance between the force potentiation and reduction depending on the fibre type. The net result of adrenergic stimulation in humans may well depend on the intensity and duration of the stimulation. Proving this in humans may be difficult. Nevertheless, the high degree of evolutionary conservation of the key molecules regulating excitation– contraction coupling strongly argues that the fundamental mechanisms are common in mammalian skeletal muscle.
Read full abstract